FI62539C - Foerfarande foer framstaellning av proteastoxoid som anvaends vid framstaellning av mot pseudomonas aeruginosainfektioner verkande trekomponentvaccin - Google Patents

Foerfarande foer framstaellning av proteastoxoid som anvaends vid framstaellning av mot pseudomonas aeruginosainfektioner verkande trekomponentvaccin Download PDF

Info

Publication number
FI62539C
FI62539C FI770169A FI770169A FI62539C FI 62539 C FI62539 C FI 62539C FI 770169 A FI770169 A FI 770169A FI 770169 A FI770169 A FI 770169A FI 62539 C FI62539 C FI 62539C
Authority
FI
Finland
Prior art keywords
protease
toxoid
oep
solution
framstaellning
Prior art date
Application number
FI770169A
Other languages
English (en)
Finnish (fi)
Other versions
FI62539B (fi
FI770169A (nl
Inventor
Yuzuru Homma
Kazuyuki Morihara
Original Assignee
Shionogi & Co
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co, Kitasato Inst filed Critical Shionogi & Co
Publication of FI770169A publication Critical patent/FI770169A/fi
Priority to FI812882A priority Critical patent/FI62540C/fi
Publication of FI62539B publication Critical patent/FI62539B/fi
Application granted granted Critical
Publication of FI62539C publication Critical patent/FI62539C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
FI770169A 1976-02-05 1977-01-20 Foerfarande foer framstaellning av proteastoxoid som anvaends vid framstaellning av mot pseudomonas aeruginosainfektioner verkande trekomponentvaccin FI62539C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI812882A FI62540C (fi) 1976-02-05 1981-09-15 Foerfarande foer framstaellning av elastastoxoid som anvaends vid framstaellning av mot pseudomonas aeruginosa-infektion verksam trekomponentvaccin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1083876A JPS5296729A (en) 1976-02-05 1976-02-05 Mixed vaccin for cyanomycosis
JP1083876 1976-02-05

Publications (3)

Publication Number Publication Date
FI770169A FI770169A (nl) 1977-08-06
FI62539B FI62539B (fi) 1982-09-30
FI62539C true FI62539C (fi) 1983-01-10

Family

ID=11761482

Family Applications (1)

Application Number Title Priority Date Filing Date
FI770169A FI62539C (fi) 1976-02-05 1977-01-20 Foerfarande foer framstaellning av proteastoxoid som anvaends vid framstaellning av mot pseudomonas aeruginosainfektioner verkande trekomponentvaccin

Country Status (11)

Country Link
US (1) US4157389A (nl)
JP (1) JPS5296729A (nl)
CA (1) CA1082595A (nl)
DE (1) DE2704766A1 (nl)
DK (1) DK144753C (nl)
FI (1) FI62539C (nl)
FR (1) FR2340099A1 (nl)
GB (1) GB1546035A (nl)
NL (1) NL7701266A (nl)
SE (1) SE425213B (nl)
SU (1) SU784796A3 (nl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1085293A (en) * 1976-02-05 1980-09-09 Yuzuru Homma Toxoids derived from protease and elastase of pseudomonas aeruginosa and production thereof
US4428931A (en) 1982-03-15 1984-01-31 Merck & Co., Inc. Bacterial toxoids and gram-negative immune globulin therefrom
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
CA1256370A (en) * 1984-02-24 1989-06-27 Yuzuru Homma Toxoids of elastase of pseudomonas aeruginosa origin
US4834976A (en) * 1986-07-03 1989-05-30 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
US4772465A (en) * 1986-10-27 1988-09-20 Miles Laboratories, Inc. Method of treating polymicrobial burn wound sepsis with a combination therapy of ciprofloxacin and pseudomonas immune globulin
US5233024A (en) * 1991-04-09 1993-08-03 The Brigham & Women's Hospital Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use
GB2523399B (en) * 2014-02-25 2019-03-13 Orban Tihamer A composition comprising ten overlapping peptide fragments of the entire preproinsulin sequence
CN109652344A (zh) * 2016-02-17 2019-04-19 中国农业科学院特产研究所 菌株及其应用，以及疫苗及其制备方法
CN110724647B (zh) * 2018-07-17 2022-11-04 黑龙江省科学院微生物研究所 一株所产内毒素蛋白对7种血清型菌株具有免疫保护作用的铜绿假单胞菌及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2528972A (en) * 1947-05-15 1950-11-07 Western Reserve University Prophylactic toxoid compound and method of making same
US3135662A (en) * 1961-01-05 1964-06-02 Burroughs Wellcome Co Diphtheria toxoid preparation and its production
US3658986A (en) * 1969-07-02 1972-04-25 Victor N Tompkins Immunization methods against toxic effects of bacterial infection
US3674863A (en) * 1969-12-08 1972-07-04 Parke Davis & Co Polyvalent immunizing agents and methods for their production
GB1365950A (en) * 1970-10-20 1974-09-04 Eisai Co Ltd Pharmaceutical composition comprising a cell wall protein compo nent of pseudomonas aeruginosa
US3987164A (en) * 1970-10-20 1976-10-19 Yuzuru Homma Method for prevention of pseudomonas aeruginosa infections
US3928565A (en) * 1971-10-19 1975-12-23 Yuzuru Homma Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties
FR2227861B1 (nl) * 1973-05-04 1976-07-02 Anvar
DE2340911A1 (de) * 1973-08-13 1975-05-07 Behringwerke Ag Tetanus-antigen und verfahren zu seiner herstellung
JPS51133489A (en) * 1975-05-14 1976-11-19 Tokyo Daigaku Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities

Also Published As

Publication number Publication date
DK144753C (da) 1982-10-25
DK144753B (da) 1982-06-01
DE2704766C2 (nl) 1988-06-16
US4157389A (en) 1979-06-05
FR2340099A1 (fr) 1977-09-02
FI62539B (fi) 1982-09-30
JPS6133010B2 (nl) 1986-07-31
GB1546035A (en) 1979-05-16
CA1082595A (en) 1980-07-29
FI770169A (nl) 1977-08-06
NL7701266A (nl) 1977-08-09
SE7701038L (sv) 1977-08-06
SE425213B (sv) 1982-09-13
DK49677A (da) 1977-08-06
JPS5296729A (en) 1977-08-13
FR2340099B1 (nl) 1981-05-08
DE2704766A1 (de) 1977-08-11
SU784796A3 (ru) 1980-11-30

Similar Documents

Publication Publication Date Title
FI62539C (fi) Foerfarande foer framstaellning av proteastoxoid som anvaends vid framstaellning av mot pseudomonas aeruginosainfektioner verkande trekomponentvaccin
US4439199A (en) Method for administering immunopotentiator
JPH06504065A (ja) 多糖類−タンパク質複合体
Maurer Attempts to produce antibodies to a preparation of polyglutamic acid.
Relyveld et al. [3] Preparation of vaccines by the action of glutaraldehyde on toxins, bacteria, viruses, allergens, and cells
JP5661744B2 (ja) 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用
HU183388B (en) Process for producing heat resistant enterotoxin derivatives of escherichia coli
Irwin et al. Enhanced resistance to Corynebacterium pseudotuberculosis infections associated with reduced serum immunoglobulin levels in levamisole-treated mice
Dolby The separation of the histamine-sensitizing factor from the protective antigens of Bordetella pertussis.
FI62540B (fi) Foerfarande foer framstaellning av elastastoxoid som anvaends vid framstaellning av mot pseudomonas aeruginosa-infektion verksam trekomponentvaccin
JPH03151400A (ja) 化学修飾されたアレルゲン類およびそれらの調製方法
RU2329828C1 (ru) Способ изготовления вакцины для профилактики и лечения некробактериоза животных, вакцина для профилактики и лечения некробактериоза животных и способ профилактики и лечения некробактериоза животных
US4160023A (en) Toxoids derived from protease and elastase of Pseudomonas aeruginosa and production thereof
Frobisher Jr et al. Further studies on the immunization of rabbits to toxigenic Corynebacterium diphtheriae by injections of nontoxigenic diphtheria bacilli
ES2945137T3 (es) Proteínas y composiciones inmunitarias que contienen proteínas de Pasteurella y métodos de uso
US4575459A (en) Toxoids of elastase of Pseudomonas aeruginosa origin
RU2076734C1 (ru) Способ получения пероральной химической вакцины
Sabolovic et al. Effect of a protein bound polysaccharide (PS-K) on tumor development and infections in splenectomized rats and mice
CA2246744C (fr) Complexe immunomodulateur et son utilisation dans les affections par helicobacter
RU2279274C2 (ru) Способ профилактики вторичного альвеолярного эхинококкоза (гидатидоза)
JPS6154769B2 (nl)
RU2093178C1 (ru) Ассоциированная вакцина против трихофитии рогатого скота и других парнокопытных
US20230256073A1 (en) Polypeptides of fusobacterium and methods of use
JPS6154770B2 (nl)
US10987415B2 (en) Process for production of purified recombinant cholera toxin B (rCTB) and formulation thereon

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SHIONOGI & CO., LTD.